They found that the automated diabetes GLP-1 prior authorization proportion of all diabetes GLP-1 claims grew by 17.5 percentage points, or 39.6%, from October 2024 to July 2025.
Automation technology is evolving, with robotic process automation having evolved into intelligent automation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback